EASTLAND JULIA MARIE (CEO & President) sold 10.0% of their position (8.76K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $21.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/10/2026ACC: 0001500189-26-000004
DirectorOfficer· CEO & President
Since Feb 2026
-8.76K
Net shares
Net seller
$21.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
8.76K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−7.87K
Price / share
$2.43
Trade value
$19.11K
% of position
9.0%
2/6/2026
87.89K→80.02K
Common Stock
Direct
Shares
−889.00
Price / share
$2.39
Trade value
$2.13K
% of position
1.1%
2/9/2026
80.02K→79.13K
Total
Net shares
−8.76K
Net value
-$21.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/6/2026 | S · Sale | −7.87K | $2.43 | $19.11K | 9.0% | 87.89K | 80.02K |
| Common Stock Direct | 2/9/2026 | S · Sale | −889.00 | $2.39 | $2.13K | 1.1% | 80.02K | 79.13K |
| Total | −8.76K | -$21.24K | ||||||
Derivative Transactions0
No derivative transactions reported